Robust and Durable Immune Response: Virus-Like Particle Vaccines

  Рет қаралды 37

astrazeneca

astrazeneca

Күн бұрын

A virus-like particle, or VLP, is a type of vaccine that engages the immune system in a manner that closely resembles interactions with actual viruses. A VLP mimics the structure of a virus, but is not infectious and hence not able to cause disease. Scientists at AstraZeneca are exploring the potential of a VLP vaccine platform to prompt a stronger immune response, greater breadth of protection and longer durability compared to non-VLP vaccines.
------------------------------------------------------------
Global site: learn.az/6057U...
Careers site: learn.az/6058U...
Follow us:
Twitter: learn.az/6059U...
LinkedIn: learn.az/6050U...
Instagram: learn.az/6051U...
Facebook: learn.az/6052U...

Пікірлер
Unlocking scientific discovery with collaboration
5:16
astrazeneca
Рет қаралды 638
Uniting for Uterine Cancer Awareness Month
20:29
astrazeneca
Рет қаралды 900
БЕЛКА СЬЕЛА КОТЕНКА?#cat
00:13
Лайки Like
Рет қаралды 2,7 МЛН
Players vs Corner Flags 🤯
00:28
LE FOOT EN VIDÉO
Рет қаралды 77 МЛН
What if cancer could be outsmarted, or maybe even cured?
1:29
Embedding Sustainability at our global R&D centre, The DISC
2:15
The use of wearables in heart failure clinical trials
2:35
astrazeneca
Рет қаралды 1,1 М.
Women in leadership
6:44
astrazeneca
Рет қаралды 834
Personalised Medicine Makes a Difference in Lung Cancer Diagnosis
2:56
Oncology Cell Therapy: engineering innovative CAR-T cells
0:54
How do TCR-Ts differ from CAR-T cell therapies?
1:09
astrazeneca
Рет қаралды 1,5 М.